Scholarly Index
David A. Gewirtz
Virginia Commonwealth University; 22,885 total citations; 271 total publications; best world rank #48
Virginia Commonwealth University
22,885Total citations
271Total publications
61H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Autophagy in Disease and Therapy | Lifetime | 146 | US 67 | 98.91 |
| Telomeres, Telomerase, and Senescence | Lifetime | 88 | US 47 | 97.80 |
| PARP inhibition in cancer therapy | Lifetime | 187 | US 97 | 97.37 |
| Cancer therapeutics and mechanisms | Lifetime | 570 | US 294 | 97.11 |
| Cancer-related Molecular Pathways | Lifetime | 896 | US 449 | 97.14 |
| Sirtuins and Resveratrol in Medicine | Lifetime | 217 | US 86 | 95.37 |
| Histone Deacetylase Inhibitors Research | Lifetime | 600 | US 290 | 94.90 |
| Cannabis and Cannabinoid Research | Lifetime | 622 | US 271 | 95.86 |
| Cell death mechanisms and regulation | Lifetime | 773 | US 315 | 95.15 |
| Calcium signaling and nucleotide metabolism | Lifetime | 928 | US 314 | 84.99 |
| Autophagy in Disease and Therapy | 2021-2025 | 95 | US 15 | 95.87 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 114 | US 52 | 93.37 |
| Telomeres, Telomerase, and Senescence | 2021-2025 | 48 | US 22 | 93.98 |
| PARP inhibition in cancer therapy | 2021-2025 | 543 | US 202 | 85.91 |
| Chemotherapy-induced organ toxicity mitigation | 2021-2025 | 233 | US 21 | 67.10 |